SecBot SecBot
144 ·Filed Oct 13, 2026

INKT

MiNK Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed15d 21h ago SEC0001973379-26-000350
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine sell-to-cover transaction for tax withholding on RSU vesting, not a discretionary insider sale. No bearish signal. Monitor the Form 4 filing to confirm execution and any change in beneficial ownership.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled: T+5d
INKT ▼ -3.62% at T+5d
NEUTRAL call -3.62% · α vs SPY -2.47% · entry $10.23 → $9.86
Next anchor: T+20d in 12d
Latest observation: T+8 +4.52% FF3 residual α
Entry = T+0 close
Oct 13, 2026
via day close
T+1d
+1.17%
call +1.17% · α +2.25%
$10.35
settled 15d ago
T+5d
-3.62%
call -3.62% · α -2.47%
$9.86
settled 9d ago
T+20d
Pending
in 12d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Jennifer Buell, President and CEO of MiNK Therapeutics, filed a Form 144 notice to sell 6,938 shares of common stock, valued at approximately $73,275, to cover tax obligations from the vesting and settlement of equity awards. The sale is a routine, non-discretionary transaction tied to RSU vesting, not a discretionary insider sale.

Key Facts

  • Insider: Jennifer Buell, President and CEO
  • Shares to be sold: 6,938 shares of common stock
  • Estimated value: $73,274.79
  • Reason: 'Shares were sold to cover obligations arising from the vesting and settlement of equity awards'
  • Total shares outstanding (as of Aug 31 10Q): 5,103,002
  • Sale represents approximately 0.14% of shares outstanding
  • Broker: Citigroup Global Markets

Financial Impact

Approximately $73,275 in shares to be sold, representing 0.14% of total shares outstanding, de minimis dilution impact.

dilution

Risk Factors

  • CEO selling any shares could be perceived negatively by retail investors unfamiliar with sell-to-cover mechanics
  • If the company's stock price declines further, the sale could amplify negative sentiment

Investment Themes

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001973379-26-000350
Document: 0001973379-26-000350.txt0001973379-26-000350
18 reports for INKT
Performance horizon
71% Hit rate @ T+20 5 of 7 directional calls Went positive at some point 5 of 7 best @ T+20▲ +16.93%May 15, 2026
Filters
Rows
Reports for INKT, sortable and filterable
TypeNow
Oct 13, 2026
15d ago
144
NEUTRAL ★ 2/10
$10.23awaiting T+20awaiting T+20$10.80 (+5.57%)
Oct 2, 2026
26d ago
Press Release
NEUTRAL ★ 4/10
$12.44awaiting T+20awaiting T+20$10.80 (−13.18%)
Aug 13, 2026
10w ago
8-K
MIXED ★ 6/10
$11.00 $12.00▲ +9.09%▲ +10.84%$10.80 (−1.82%)
Aug 13, 2026
10w ago
Press Release
MIXED ★ 6/10
$11.00 $12.00▲ +9.09%▲ +10.84%$10.80 (−1.82%)
Aug 6, 2026
11w ago
Press Release
BULLISH ★ 6/10
$11.00 $11.23▲ +2.09%▲ +1.49%$10.80 (−1.82%)
May 28, 2026
21w ago
Press Release
NEUTRAL ★ 4/10
$12.20 $11.64▼ −4.59%▼ −1.45%$10.80 (−11.48%)
May 20, 2026
23w ago
Press Release
NEUTRAL ★ 4/10
$10.72 $12.14▲ +13.25%▲ +12.51%$10.80 (+0.75%)
May 15, 2026
23w ago
8-K
NEUTRAL ★ 5/10
$10.72 $12.54▲ +16.93%▲ +14.81%$10.80 (+0.75%)
May 15, 2026
23w ago
Press Release
BULLISH ★ 6/10
$10.72 $12.54▲ +16.93%▲ +14.81%$10.80 (+0.75%)
May 14, 2026
23w ago
Press Release
BULLISH ★ 7/10
$10.51 $12.02▲ +14.37%▲ +15.23%$10.80 (+2.76%)
Showing 10 of 18

US Market Status

Market Closed · Opens in 3h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 13, 2026